In a trial of a cytotoxic drug for lung cancer treatment, the investigators reported 6 deaths among 60 patients treated with this agent, compared with 15 deaths among 58 controls on placebo. Calculate the attributable benefit of this agent in reducing lung cancer-related mortality in this population.
A. 10.0%
B. 25.8%
C. 15.8%
D. 5.8%
ANSWER::
In the given problem,
initially 15 deaths among 58 controls on Plecebo i.e 25.9%
After the treatment 10 deaths among the 60 patient treats i.e 16.6%
Then the difference in deaths after treatment is ---- 10% approximately.
OPTION: (A) IS CORRECT (10.0%)
This question does not need further explanation.
NOTE:: I HOPE YOUR HAPPY WITH MY ANSWER....***PLEASE SUPPORT ME WITH YOUR RATING...
***PLEASE GIVE ME "LIKE"...ITS VERY IMPORTANT FOR ME NOW....PLEASE SUPPORT ME ....THANK YOU
Get Answers For Free
Most questions answered within 1 hours.